Wisconsin 2025-2026 Regular Session

Wisconsin Assembly Bill AJR23 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	2025 - 2026 LEGISLATURE
2	2	LRB-1685/1
3	3	DJW:klm&wlj
4	4	2025 ASSEMBLY JOINT RESOLUTION 23
5	5	April 15, 2025 - Introduced by Representatives SUBECK, KAUFERT, BARE, BROWN,
6	6	CLANCY, DESMIDT, EMERSON, JOERS, KITCHENS, KNODL, MADISON,
7	7	MCCARVILLE, MELOTIK, MIRESSE, MURPHY, MURSAU, NOVAK, ORTIZ-VELEZ,
8	8	PIWOWARCZYK, ROE, STUBBS, TRANEL, UDELL, VINING and WITTKE,
9	9	cosponsored by Senators CABRAL-GUEVARA, CARPENTER, DRAKE, HESSELBEIN,
10	10	L. JOHNSON, RATCLIFF, ROYS, SPREITZER, WANGGAARD and WIRCH. Referred to
11	11	Committee on Rules.
12	12
13	13	*AUTHORS SUBJECT TO CHANGE*
14	14	Relating to: designating April 2025 and April 2026 as Parkinson[s Disease
15	15	Awareness Months.
16	16	Whereas, Parkinson[s disease is a chronic, progressive, neurological disease
17	17	and is the second-most-common neurodegenerative disease in the United States;
18	18	and
19	19	Whereas, Parkinson[s disease is estimated to affect approximately one million
20	20	people in the United States, and the prevalence will rise to 1.2 million by 2030; and
21	21	Whereas, 90,000 people are diagnosed with Parkinson[s disease each year in
22	22	the United States; and
23	23	Whereas, Parkinson[s disease is the 14th-leading cause of death in the United
24	24	States, according to the Centers for Disease Control and Prevention; and
25	25	Whereas, it is estimated that the economic burden of Parkinson[s disease is at
26	26	least $52 billion annually, including direct costs, such as treatment, and indirect
27	27	costs, such as lost income; and
28	28	1
29	29	2
30	30	3
31	31	4
32	32	5
33	33	6
34	34	7
35	35	8
36	36	9
37	37	10
38	38	11
39	39	12
40	40	13
41	41	14 2025 - 2026 Legislature - 2 - LRB-1685/1
42	42	DJW:klm&wlj
43	43	Whereas, research suggests the cause of Parkinson[s disease is a combination
44	44	of genetic and environmental factors, but the exact cause of the disease is still
45	45	unknown; and
46	46	Whereas, there is no objective test or biomarker for Parkinson[s disease, and
47	47	there is presently no cure or drug that slows or halts the progression of the disease;
48	48	and
49	49	Whereas, the symptoms of Parkinson[s disease vary from person to person and
50	50	can include tremors; slowness of movement; rigidity; cognitive impairment;
51	51	dementia; mood disorders; difficulty with balance, swallowing, chewing, and
52	52	speaking; and a variety of other nonmotor symptoms; and
53	53	Whereas, volunteers, researchers, caregivers, and medical professionals are
54	54	working to improve the quality of life of persons living with Parkinson[s disease and
55	55	their families; and
56	56	Whereas, increased research, education, and community support services,
57	57	such as those provided by the Michael J. Fox Foundation, Davis Phinney
58	58	Foundation, Parkinson[s Foundation, Wisconsin Parkinson Association, and other
59	59	organizations, are needed to find more effective treatments and to provide access to
60	60	quality care to those living with the disease today; now, therefore, be it
61	61	Resolved by the assembly, the senate concurring, That April 2025 and
62	62	April 2026 are hereby designated Parkinson[s Disease Awareness Months in
63	63	Wisconsin.
64	64	(END)
65	65	1
66	66	2
67	67	3
68	68	4
69	69	5
70	70	6
71	71	7
72	72	8
73	73	9
74	74	10
75	75	11
76	76	12
77	77	13
78	78	14
79	79	15
80	80	16
81	81	17
82	82	18
83	83	19
84	84	20
85	85	21
86	86	22